March 21, 2018 News by Patricia Inacio, PhD Blood Stem Cell Transplants Improve RRMS Patients’ Disability, Phase 3 Trial Shows Blood stem cell transplants lead to significant improvements inĀ relapsing-remitting multiple sclerosis patients’ disability, a Phase 3 clinical trial shows. The 110 patients who took part in the MIST study (NCT00273364) were having relapses after receiving standard therapies such asĀ beta interferon, Copaxone (glatiramer acetate), Novantrone (mitoxantrone), Tysabri (natalizumab), Gilenya (fingolimod),…
February 21, 2017 News by Patricia Silva, PhD Stem Cell Transplants of Greatest Benefit to RMS Patients at Earlier Disease Stages, Study Says Stem cell transplants are most effectiveĀ if doneĀ in young multiple sclerosis (MS) patients in early disease stages, who have not gone through several rounds of other treatments, according to a large study that followed transplant patients for more than five years. Study results alsoĀ found that people with relapsing MS are much…
February 14, 2017 Columns by Ed Tobias Stem Cell Treatment for MS: Can’t We Move Any Faster? There is some good news about stem cell therapy. A just-published study concludes that one form of human stem cell therapy is more effective at treating multiple sclerosis than the best of the MS medications being used currently. The not-so-good news is that approval of this…
June 14, 2016 News by Patricia Silva, PhD Aggressive Stem Cell Transplant Approach Halts MS for Years, But Risks are High Autologous haematopoietic stem cell transplantation (aHSCT) has been used to stop autoimmune processes in multiple sclerosis (MS), althoughĀ the treatment is not effectiveĀ for every person. Now, an improved version of the technique is showing astonishingly good results, with patients free ofĀ both the need for treatment and the risk of relapses for…
June 13, 2016 Columns by admin Stem Cell MS Patients Lead Normal Life Thanks To aHSCT Procedure People with MS who were involved in a long-term clinical trial are out and about enjoying a full and normal life with no signs of the disease. This follows their recovery from the stem cell transplants involving aggressive chemotherapy, or aHSCT as the procedure is known. Results of the clinical…
June 10, 2016 by admin Aggressive Stem Cell Therapy Stops MS Relapses, According to Long-term Clinical Trial Stem cell treatment has been proven to both halt MS clinical relapses and the development of new brain lesions over a prolonged period, according to the results of a new study. The results, achieved in 23 out of 24 patients in a Phase 2 clinical trial, were published in…
June 6, 2016 Columns by admin Stem Cell Transplants – an Exciting MS Therapy Development Stem cell treatment of MS, whichĀ came under the spotlight at last weekās 16th Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) when Dr. Mark Freedman discussed the procedure, is an exciting area within the development of therapies. Dr. Freedman, professor of medicine (neurology) at the…